Alpha Cognition Inc. Investment Income, Interest
Alpha Cognition Inc. (ACOG) reported Investment Income, Interest of $380.74 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- Alpha Cognition Inc. investment income, interest for the quarter ending 2026-06-30 was $380.74K, a 10.56% decline year-over-year.
- Alpha Cognition Inc. investment income, interest for the quarter ending 2026-03-31 was $506.06K, a 9.57% increase year-over-year.
- Alpha Cognition Inc. investment income, interest for the quarter ending 2025-06-30 was $425.67K, a 19606.94% increase year-over-year.
- Alpha Cognition Inc. investment income, interest for the quarter ending 2025-03-31 was $461.87K, a 3726.59% increase year-over-year.
- Alpha Cognition Inc. investment income, interest for fiscal 2024 was $161.66K, a 2276.01% increase from fiscal 2023.
- Alpha Cognition Inc. investment income, interest for fiscal 2023 was $6.80K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380.74K 10-Q · filed 2026-08-13 | $886.79K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | $506.06K 10-Q · filed 2026-05-14 | |||||
| 2025-06-30 | $425.67K 10-Q · filed 2026-08-13 | $425.03K 10-Q · filed 2025-08-14 | $887.54K 10-Q · filed 2026-08-13 | $895.70K 10-Q · filed 2025-08-14 | $1.03M derived: sum of 3 quarters · filed 2026-08-13 | $1.03M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $461.87K 10-Q · filed 2026-05-14 | $470.68K 10-Q · filed 2025-05-15 | $607.39K derived: sum of 2 quarters · filed 2026-05-14 | $609.30K derived: sum of 3 quarters · filed 2026-05-14 | $611.46K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $145.52K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $147.43K derived: sum of 2 quarters · filed 2025-03-31 | $149.59K derived: sum of 3 quarters · filed 2025-08-14 | $161.66K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $1.92K 10-Q · filed 2024-11-14 | $4.08K derived: sum of 2 quarters · filed 2025-08-14 | $16.15K 10-Q · filed 2024-11-14 | $17.89K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-06-30 | $2.16K 10-Q · filed 2025-08-14 | $14.23K 10-Q · filed 2025-08-14 | $15.97K derived: sum of 3 quarters · filed 2025-08-14 | $18.69K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $12.07K 10-Q · filed 2025-05-15 | $13.81K derived: sum of 2 quarters · filed 2025-05-15 | $16.53K derived: sum of 3 quarters · filed 2025-05-15 | $18.70K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $1.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.46K derived: sum of 2 quarters · filed 2025-03-31 | $6.63K derived: sum of 3 quarters · filed 2025-03-31 | $6.80K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $2.71K 10-Q · filed 2024-11-14 | $4.89K derived: sum of 2 quarters · filed 2024-11-14 | $5.06K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $2.17K 10-Q · filed 2024-08-12 | $2.35K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |